Haploinsufficiency of EXT1 and Heparan Sulphate Deficiency Associated with Hereditary Multiple Exostoses in a Pakistani Family

Background and Objectives: Hereditary multiple exostoses (HME) is a disease characterized by cartilage-capped bony protuberances at the site of growth plates of long bones. Functional mutations in the exostosin genes (EXT1 and EXT2) are reported to affect the hedgehog signalling pathways leading to multiple enchondromatosis. However, the exact role of each EXT protein in the regulation of heparan sulphate (HS) chain elongation is still an enigma. In this study, a Pakistani family with HME is investigated to find out the genetic basis of the disease. Materials and Methods: Genotyping of eight members of the family by amplifying microsatellite markers, tightly linked to the EXT1 and EXT2 genes. Results: The study revealed linkage of the HME family to the EXT1 locus 8q24.1. Sanger sequencing identified a heterozygous deletion (c.247Cdel) in exon 1 of EXT1, segregating with the disease phenotype in the family. In silico analysis predicted a shift in the frame causing an early stop codon (p.R83GfsX52). The predicted dwarf protein constituting 134 amino acids was functionally aberrant with a complete loss of the catalytic domain at the C-terminus. Interestingly, an alternative open reading frame 3 (ORF3) caused by the frame shift is predicted to encode a protein sequence, identical to the wild type and containing the catalytic domain, but lacking the first 100 amino acids of the wild-type EXT1 protein. Conclusion: Consequently, haploinsufficiency could be the cause of HME in the investigated family as the mutated copy of EXT1 is ineffective for EXT-1/2 complex formation. The predicted ORF3 protein could be of great significance in understanding several aspects of HME pathogenesis.

[1]  Seok-Yong Choi,et al.  A Genotype-Phenotype Study of Multiple Hereditary Exostoses in Forty-Three Patients , 2022, Journal of clinical medicine.

[2]  Huayu Wu,et al.  Mutational Analysis of EXT1in a Chinese Family Affected by Hereditary Multiple Osteochondroma , 2021, BioMed research international.

[3]  Xia Li,et al.  A novel mutation in ext2 caused hereditary multiple exostoses through reducing the synthesis of heparan sulfate , 2021, Genetics and molecular biology.

[4]  M. Zou,et al.  Mutation spectrum of EXT1 and EXT2 in the Saudi patients with hereditary multiple exostoses , 2021, Orphanet Journal of Rare Diseases.

[5]  P. Ma,et al.  Identification of a novel mutation in the EXT1 gene from a patient with multiple osteochondromas by exome sequencing , 2016, Molecular medicine reports.

[6]  G. Beltrami,et al.  Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern. , 2016, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[7]  L. Zhuang,et al.  Deletion of exon 8 from the EXT1 gene causes multiple osteochondromas (MO) in a family with three affected members , 2016, SpringerPlus.

[8]  V. Delcourt,et al.  Death of a dogma: eukaryotic mRNAs can code for more than one protein , 2015, Nucleic acids research.

[9]  K. Jochmann,et al.  Reprint of: Heparan sulfate as a regulator of endochondral ossification and osteochondroma development. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[10]  Q. Bi,et al.  Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses. , 2014, Oncology reports.

[11]  Matthew Fraser,et al.  InterProScan 5: genome-scale protein function classification , 2014, Bioinform..

[12]  Yang Zhang,et al.  The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.

[13]  Yang Luo,et al.  Novel and recurrent mutations in the EXT1 and EXT2 genes in Chinese kindreds with multiple osteochondromas , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[14]  J. Dormans,et al.  Heparan sulfate in skeletal development, growth, and pathology: The case of hereditary multiple exostoses , 2013, Developmental dynamics : an official publication of the American Association of Anatomists.

[15]  François-Michel Boisvert,et al.  Direct Detection of Alternative Open Reading Frames Translation Products in Human Significantly Expands the Proteome , 2013, PloS one.

[16]  P. Lapunzina,et al.  Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas , 2013, Scientific Reports.

[17]  Vassilios Ioannidis,et al.  ExPASy: SIB bioinformatics resource portal , 2012, Nucleic Acids Res..

[18]  P. Rose.  Genotype-Phenotype Correlation Study in 529 Patients with Multiple Hereditary Exostoses: Identification of “Protective” and “Risk” Factors , 2012 .

[19]  Saverio Brogna,et al.  Nonsense-mediated mRNA decay (NMD) mechanisms , 2009, Nature Structural &Molecular Biology.

[20]  A. Varki,et al.  Cellular Organization of Glycosylation , 2009 .

[21]  L. Kjellén,et al.  Contribution of EXT1, EXT2, and EXTL3 to Heparan Sulfate Chain Elongation* , 2007, Journal of Biological Chemistry.

[22]  A. Munnich,et al.  Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients. , 2006, Bone.

[23]  M. Razzaque,et al.  Conditional deletion of Indian hedgehog from collagen type 2α1‐expressing cells results in abnormal endochondral bone formation , 2005, The Journal of pathology.

[24]  N. Perrimon,et al.  Developmental cell biology: Heparan sulphate proteoglycans: the sweet side of development , 2005, Nature Reviews Molecular Cell Biology.

[25]  David S. Wishart,et al.  SuperPose: a simple server for sophisticated structural superposition , 2004, Nucleic Acids Res..

[26]  H. Kronenberg,et al.  Developmental regulation of the growth plate , 2003, Nature.

[27]  C. McCormick,et al.  The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins. , 2001, The Journal of clinical investigation.

[28]  H. Kitagawa,et al.  The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis , 2000, EMBO reports.

[29]  J. Paulson,et al.  Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. , 1989, The Journal of biological chemistry.